Effects of Stress Hyperglycemia on Acute Myocardial Infarction
Effects of Stress Hyperglycemia on Acute Myocardial Infarction Role of inflammatory immune process in functional cardiac outcome Raffaele Marfella , MD, PHD 1 2 , Mario Siniscalchi , MD, PHD 1 , Katherine Esposito , MD 1 2 , Ausilia Sellitto , MD 1 , Umberto de Fanis , MD 1 , Ciro Romano , MD, PHD 1...
Gespeichert in:
Veröffentlicht in: | Diabetes care 2003-11, Vol.26 (11), p.3129-3135 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3135 |
---|---|
container_issue | 11 |
container_start_page | 3129 |
container_title | Diabetes care |
container_volume | 26 |
creator | Marfella, Raffaele Siniscalchi, Mario Esposito, Katherine Sellitto, Ausilia de Fanis, Umberto Romano, Ciro Portoghese, Michele Siciliano, Silvio Nappo, Francesco Sasso, Ferdinando Carlo Mininni, Nicola Cacciapuoti, Federico Lucivero, Giacomo Giunta, Riccardo Verza, Mario Giugliano, Dario |
description | Effects of Stress Hyperglycemia on Acute Myocardial Infarction
Role of inflammatory immune process in functional cardiac outcome
Raffaele Marfella , MD, PHD 1 2 ,
Mario Siniscalchi , MD, PHD 1 ,
Katherine Esposito , MD 1 2 ,
Ausilia Sellitto , MD 1 ,
Umberto de Fanis , MD 1 ,
Ciro Romano , MD, PHD 1 ,
Michele Portoghese , MD 3 ,
Silvio Siciliano , MD 4 ,
Francesco Nappo , MD, PHD 1 ,
Ferdinando Carlo Sasso , MD, PHD 1 ,
Nicola Mininni , MD 4 ,
Federico Cacciapuoti , MD 1 ,
Giacomo Lucivero , MD, PHD 1 ,
Riccardo Giunta , MD 1 ,
Mario Verza , MD 1 and
Dario Giugliano , MD, PHD 1 2
1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy
2 Cardiovascular Research Center, Second University of Naples, Naples, Italy
3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy
4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy
Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail:
raffaele.marfella{at}unina2.it
Abstract
OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined
the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac
outcome in patients with first MI.
RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of
CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency
ward.
RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher
in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared
with normoglycemic patients ( P < 0.001).
CONCLUSIONS —During MI, hyperglycemia is associated with increased l |
doi_str_mv | 10.2337/diacare.26.11.3129 |
format | Article |
fullrecord | <record><control><sourceid>highwire_cross</sourceid><recordid>TN_cdi_highwire_diabetes_diacare_26_11_3129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>diacare_26_11_3129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</originalsourceid><addsrcrecordid>eNptkEtPAjEUhRujEUT_gKvuzYy9fUzbjQkhICQYF-q6KX3AmIEh7Rgz_94hsHR1Fvece04-hB6BlJQx-exr62wKJa1KgJIB1VdoDJqJQgiurtGYANeF0JqO0F3O34QQzpW6RSPgQioqyBi9zGMMrsu4jfijSyFnvOyPIW2b3oV9bXF7wFP30wX81rdD29DZ4NUh2uS6uj3co5tomxweLjpBX4v552xZrN9fV7PpunCgOS90ZNQxTsB5AhG8H3ZUjGhBlJKOOMWpl0CkjFJqzjZRhQ1Y512wQgvt2QTR81-X2pxTiOaY6r1NvQFiTjDMBYahlQEwJxhD6Okc2tXb3W89HAfTJnQh_-f-A1H2YNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Marfella, Raffaele ; Siniscalchi, Mario ; Esposito, Katherine ; Sellitto, Ausilia ; de Fanis, Umberto ; Romano, Ciro ; Portoghese, Michele ; Siciliano, Silvio ; Nappo, Francesco ; Sasso, Ferdinando Carlo ; Mininni, Nicola ; Cacciapuoti, Federico ; Lucivero, Giacomo ; Giunta, Riccardo ; Verza, Mario ; Giugliano, Dario</creator><creatorcontrib>Marfella, Raffaele ; Siniscalchi, Mario ; Esposito, Katherine ; Sellitto, Ausilia ; de Fanis, Umberto ; Romano, Ciro ; Portoghese, Michele ; Siciliano, Silvio ; Nappo, Francesco ; Sasso, Ferdinando Carlo ; Mininni, Nicola ; Cacciapuoti, Federico ; Lucivero, Giacomo ; Giunta, Riccardo ; Verza, Mario ; Giugliano, Dario</creatorcontrib><description><![CDATA[Effects of Stress Hyperglycemia on Acute Myocardial Infarction
Role of inflammatory immune process in functional cardiac outcome
Raffaele Marfella , MD, PHD 1 2 ,
Mario Siniscalchi , MD, PHD 1 ,
Katherine Esposito , MD 1 2 ,
Ausilia Sellitto , MD 1 ,
Umberto de Fanis , MD 1 ,
Ciro Romano , MD, PHD 1 ,
Michele Portoghese , MD 3 ,
Silvio Siciliano , MD 4 ,
Francesco Nappo , MD, PHD 1 ,
Ferdinando Carlo Sasso , MD, PHD 1 ,
Nicola Mininni , MD 4 ,
Federico Cacciapuoti , MD 1 ,
Giacomo Lucivero , MD, PHD 1 ,
Riccardo Giunta , MD 1 ,
Mario Verza , MD 1 and
Dario Giugliano , MD, PHD 1 2
1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy
2 Cardiovascular Research Center, Second University of Naples, Naples, Italy
3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy
4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy
Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail:
raffaele.marfella{at}unina2.it
Abstract
OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined
the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac
outcome in patients with first MI.
RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of
CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency
ward.
RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher
in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared
with normoglycemic patients ( P < 0.001).
CONCLUSIONS —During MI, hyperglycemia is associated with increased levels of inflammatory markers, enhanced expression of cytotoxic T-cells,
and reduced expression of T-cells, which are implicated in limiting the immune process. An increased inflammatory immune process
seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients.
CRP, C-reactive protein
ECG, electrocardiogram
ET, ejection time
ICT, isovolumetric contracting time
IL-18, interleukin-18
IRT, isovolumetric relaxation time
MI, myocardial infarction
MPI, myocardial performance index
Footnotes
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Accepted July 30, 2003.
Received May 20, 2003.
DIABETES CARE]]></description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.26.11.3129</identifier><identifier>PMID: 14578250</identifier><language>eng</language><publisher>American Diabetes Association</publisher><ispartof>Diabetes care, 2003-11, Vol.26 (11), p.3129-3135</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</citedby><cites>FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Marfella, Raffaele</creatorcontrib><creatorcontrib>Siniscalchi, Mario</creatorcontrib><creatorcontrib>Esposito, Katherine</creatorcontrib><creatorcontrib>Sellitto, Ausilia</creatorcontrib><creatorcontrib>de Fanis, Umberto</creatorcontrib><creatorcontrib>Romano, Ciro</creatorcontrib><creatorcontrib>Portoghese, Michele</creatorcontrib><creatorcontrib>Siciliano, Silvio</creatorcontrib><creatorcontrib>Nappo, Francesco</creatorcontrib><creatorcontrib>Sasso, Ferdinando Carlo</creatorcontrib><creatorcontrib>Mininni, Nicola</creatorcontrib><creatorcontrib>Cacciapuoti, Federico</creatorcontrib><creatorcontrib>Lucivero, Giacomo</creatorcontrib><creatorcontrib>Giunta, Riccardo</creatorcontrib><creatorcontrib>Verza, Mario</creatorcontrib><creatorcontrib>Giugliano, Dario</creatorcontrib><title>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</title><title>Diabetes care</title><description><![CDATA[Effects of Stress Hyperglycemia on Acute Myocardial Infarction
Role of inflammatory immune process in functional cardiac outcome
Raffaele Marfella , MD, PHD 1 2 ,
Mario Siniscalchi , MD, PHD 1 ,
Katherine Esposito , MD 1 2 ,
Ausilia Sellitto , MD 1 ,
Umberto de Fanis , MD 1 ,
Ciro Romano , MD, PHD 1 ,
Michele Portoghese , MD 3 ,
Silvio Siciliano , MD 4 ,
Francesco Nappo , MD, PHD 1 ,
Ferdinando Carlo Sasso , MD, PHD 1 ,
Nicola Mininni , MD 4 ,
Federico Cacciapuoti , MD 1 ,
Giacomo Lucivero , MD, PHD 1 ,
Riccardo Giunta , MD 1 ,
Mario Verza , MD 1 and
Dario Giugliano , MD, PHD 1 2
1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy
2 Cardiovascular Research Center, Second University of Naples, Naples, Italy
3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy
4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy
Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail:
raffaele.marfella{at}unina2.it
Abstract
OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined
the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac
outcome in patients with first MI.
RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of
CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency
ward.
RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher
in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared
with normoglycemic patients ( P < 0.001).
CONCLUSIONS —During MI, hyperglycemia is associated with increased levels of inflammatory markers, enhanced expression of cytotoxic T-cells,
and reduced expression of T-cells, which are implicated in limiting the immune process. An increased inflammatory immune process
seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients.
CRP, C-reactive protein
ECG, electrocardiogram
ET, ejection time
ICT, isovolumetric contracting time
IL-18, interleukin-18
IRT, isovolumetric relaxation time
MI, myocardial infarction
MPI, myocardial performance index
Footnotes
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Accepted July 30, 2003.
Received May 20, 2003.
DIABETES CARE]]></description><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNptkEtPAjEUhRujEUT_gKvuzYy9fUzbjQkhICQYF-q6KX3AmIEh7Rgz_94hsHR1Fvece04-hB6BlJQx-exr62wKJa1KgJIB1VdoDJqJQgiurtGYANeF0JqO0F3O34QQzpW6RSPgQioqyBi9zGMMrsu4jfijSyFnvOyPIW2b3oV9bXF7wFP30wX81rdD29DZ4NUh2uS6uj3co5tomxweLjpBX4v552xZrN9fV7PpunCgOS90ZNQxTsB5AhG8H3ZUjGhBlJKOOMWpl0CkjFJqzjZRhQ1Y512wQgvt2QTR81-X2pxTiOaY6r1NvQFiTjDMBYahlQEwJxhD6Okc2tXb3W89HAfTJnQh_-f-A1H2YNA</recordid><startdate>20031101</startdate><enddate>20031101</enddate><creator>Marfella, Raffaele</creator><creator>Siniscalchi, Mario</creator><creator>Esposito, Katherine</creator><creator>Sellitto, Ausilia</creator><creator>de Fanis, Umberto</creator><creator>Romano, Ciro</creator><creator>Portoghese, Michele</creator><creator>Siciliano, Silvio</creator><creator>Nappo, Francesco</creator><creator>Sasso, Ferdinando Carlo</creator><creator>Mininni, Nicola</creator><creator>Cacciapuoti, Federico</creator><creator>Lucivero, Giacomo</creator><creator>Giunta, Riccardo</creator><creator>Verza, Mario</creator><creator>Giugliano, Dario</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20031101</creationdate><title>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</title><author>Marfella, Raffaele ; Siniscalchi, Mario ; Esposito, Katherine ; Sellitto, Ausilia ; de Fanis, Umberto ; Romano, Ciro ; Portoghese, Michele ; Siciliano, Silvio ; Nappo, Francesco ; Sasso, Ferdinando Carlo ; Mininni, Nicola ; Cacciapuoti, Federico ; Lucivero, Giacomo ; Giunta, Riccardo ; Verza, Mario ; Giugliano, Dario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marfella, Raffaele</creatorcontrib><creatorcontrib>Siniscalchi, Mario</creatorcontrib><creatorcontrib>Esposito, Katherine</creatorcontrib><creatorcontrib>Sellitto, Ausilia</creatorcontrib><creatorcontrib>de Fanis, Umberto</creatorcontrib><creatorcontrib>Romano, Ciro</creatorcontrib><creatorcontrib>Portoghese, Michele</creatorcontrib><creatorcontrib>Siciliano, Silvio</creatorcontrib><creatorcontrib>Nappo, Francesco</creatorcontrib><creatorcontrib>Sasso, Ferdinando Carlo</creatorcontrib><creatorcontrib>Mininni, Nicola</creatorcontrib><creatorcontrib>Cacciapuoti, Federico</creatorcontrib><creatorcontrib>Lucivero, Giacomo</creatorcontrib><creatorcontrib>Giunta, Riccardo</creatorcontrib><creatorcontrib>Verza, Mario</creatorcontrib><creatorcontrib>Giugliano, Dario</creatorcontrib><collection>CrossRef</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marfella, Raffaele</au><au>Siniscalchi, Mario</au><au>Esposito, Katherine</au><au>Sellitto, Ausilia</au><au>de Fanis, Umberto</au><au>Romano, Ciro</au><au>Portoghese, Michele</au><au>Siciliano, Silvio</au><au>Nappo, Francesco</au><au>Sasso, Ferdinando Carlo</au><au>Mininni, Nicola</au><au>Cacciapuoti, Federico</au><au>Lucivero, Giacomo</au><au>Giunta, Riccardo</au><au>Verza, Mario</au><au>Giugliano, Dario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</atitle><jtitle>Diabetes care</jtitle><date>2003-11-01</date><risdate>2003</risdate><volume>26</volume><issue>11</issue><spage>3129</spage><epage>3135</epage><pages>3129-3135</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><abstract><![CDATA[Effects of Stress Hyperglycemia on Acute Myocardial Infarction
Role of inflammatory immune process in functional cardiac outcome
Raffaele Marfella , MD, PHD 1 2 ,
Mario Siniscalchi , MD, PHD 1 ,
Katherine Esposito , MD 1 2 ,
Ausilia Sellitto , MD 1 ,
Umberto de Fanis , MD 1 ,
Ciro Romano , MD, PHD 1 ,
Michele Portoghese , MD 3 ,
Silvio Siciliano , MD 4 ,
Francesco Nappo , MD, PHD 1 ,
Ferdinando Carlo Sasso , MD, PHD 1 ,
Nicola Mininni , MD 4 ,
Federico Cacciapuoti , MD 1 ,
Giacomo Lucivero , MD, PHD 1 ,
Riccardo Giunta , MD 1 ,
Mario Verza , MD 1 and
Dario Giugliano , MD, PHD 1 2
1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy
2 Cardiovascular Research Center, Second University of Naples, Naples, Italy
3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy
4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy
Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail:
raffaele.marfella{at}unina2.it
Abstract
OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined
the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac
outcome in patients with first MI.
RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of
CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency
ward.
RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher
in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared
with normoglycemic patients ( P < 0.001).
CONCLUSIONS —During MI, hyperglycemia is associated with increased levels of inflammatory markers, enhanced expression of cytotoxic T-cells,
and reduced expression of T-cells, which are implicated in limiting the immune process. An increased inflammatory immune process
seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients.
CRP, C-reactive protein
ECG, electrocardiogram
ET, ejection time
ICT, isovolumetric contracting time
IL-18, interleukin-18
IRT, isovolumetric relaxation time
MI, myocardial infarction
MPI, myocardial performance index
Footnotes
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Accepted July 30, 2003.
Received May 20, 2003.
DIABETES CARE]]></abstract><pub>American Diabetes Association</pub><pmid>14578250</pmid><doi>10.2337/diacare.26.11.3129</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-5992 |
ispartof | Diabetes care, 2003-11, Vol.26 (11), p.3129-3135 |
issn | 0149-5992 1935-5548 |
language | eng |
recordid | cdi_highwire_diabetes_diacare_26_11_3129 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
title | Effects of Stress Hyperglycemia on Acute Myocardial Infarction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-highwire_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Stress%20Hyperglycemia%20on%20Acute%20Myocardial%20Infarction&rft.jtitle=Diabetes%20care&rft.au=Marfella,%20Raffaele&rft.date=2003-11-01&rft.volume=26&rft.issue=11&rft.spage=3129&rft.epage=3135&rft.pages=3129-3135&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/diacare.26.11.3129&rft_dat=%3Chighwire_cross%3Ediacare_26_11_3129%3C/highwire_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14578250&rfr_iscdi=true |